enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Cancer Treatment Centers of America - Wikipedia

   en.wikipedia.org/wiki/Cancer_Treatment_Centers...

   Cancer Treatment Centers of America (CTCA) was founded in 1988 by Richard J. Stephenson following the death of his mother, Mary Brown Stephenson, who died from lung cancer. [3] Stephenson purchased the American International Hospital in Zion, Illinois , in 1988 and expanded the hospital to include a radiation center, the Mary Brown Stephenson ...

3. Merck stops testing combo drug for lung cancer - AOL

   www.aol.com/news/merck-stops-testing-combo-drug...

   (Reuters) -Merck said on Thursday it had discontinued a trial testing a combination immunotherapy treatment in patients with a type of lung cancer after an interim analysis showed the drug was ...

4. Merck's Keytruda gets FDA nod for expanded use in lung cancer

   www.aol.com/news/mercks-keytruda-gets-u-fdas...

   The U.S. health regulator's approval extends Keytruda's use in combination with chemotherapy as a treatment given before surgery to shrink the size of the tumor in patients. The U.S. drugmaker is ...

5. Merck scraps two late-stage trials of cancer drug Keytruda

   www.aol.com/news/merck-scraps-two-stage-trials...

   A trial of the drug in patients with an advanced type of skin cancer called cutaneous squamous cell carcinoma was stopped for "futility", meaning it was likely to fail, the company said.

6. Merck's lung cancer drug combo fails trial in setback for new ...

   www.aol.com/news/mercks-lung-cancer-drug-combo...

   Merck's experimental anti-TIGIT drug vibostolimab in combination with its approved therapy Keytruda also failed to improve overall survival in a study of patients with non-small-cell lung cancer ...

7. Merck's Keytruda sets new 5-year survival standard for ... - AOL

   www.aol.com/news/mercks-keytruda-sets-5-survival...

   Nearly a quarter of patients who received Merck & Co's immunotherapy Keytruda as an initial treatment for advanced lung cancer were still alive after five years, according to data presented at a ...

8. Merck Gets FDA Nod for Keytruda Lung Cancer Label Expansion - AOL

   www.aol.com/news/merck-gets-fda-nod-keytruda...

   Merck (MRK) gets FDA approval to include overall survival data from a key late-stage lung cancer study, KEYNOTE-189 study, on the label of its PD-L1 inhibitor, Keytruda.

9. Merck, Novocure Team Up On Lung Cancer Treatment; Trial ... - AOL

   www.aol.com/news/merck-novocure-team-lung-cancer...

   Merck (MRK) and Novocure (NVCR) have entered into a clinical trial collaboration agreement to develop Tumor Treating Fields together with Merck’s anti-PD-1 therapy Keytruda (pembrolizumab) for ...